JB

Jochen Buck

SR Sloan Kettering Institute For Cancer Research: 14 patents #24 of 644Top 4%
CF Cornell Research Foundation: 7 patents #89 of 1,638Top 6%
CU Columbia University: 6 patents #206 of 2,492Top 9%
CU Cornell University: 3 patents #259 of 1,984Top 15%
📍 Stamford, CT: #44 of 1,447 inventorsTop 4%
🗺 Connecticut: #1,653 of 34,797 inventorsTop 5%
Overall (All Time): #183,108 of 4,157,543Top 5%
23
Patents All Time

Issued Patents All Time

Showing 1–23 of 23 patents

Patent #TitleCo-InventorsDate
10981899 Inhibitors of soluble adenylyl cyclase Lonny Levin, Lavoisier Ramos-Espiritu, Clemens Steegborn, Ayumu Sato, Rei Okamoto +1 more 2021-04-20
9649295 Chemical inhibitors of soluble adenylyl cyclase (sAC) Lonny Levin, Fritz A. Muhlschlegel 2017-05-16
9388250 Method to treat psoriasis and other hyperproliferative skin disorders Lonny Levin, Jonathan Zippin 2016-07-12
9095578 Adenylyl cyclases as novel targets for the treatment of infection by eukaryotic pathogens Lonny Levin, Leo Brizuela, Michael D. Pinnisi 2015-08-04
9017681 Adenylyl cyclases as novel targets for antibactrial interventions Lonny Levin, Leo Brizuela, Michael D. Pinnisi 2015-04-28
8859213 Method for diagnosing melanocytic proliferations Cynthia Magro, Jonathan Zippin, Lonny Levin 2014-10-14
6544768 Mammalian soluble adenylyl cyclase Lonny Levin 2003-04-08
6403559 C-kit ligand-based method for expanding peripheral blood cell levels Peter Besmer, Malcolm A. S. Moore, Karl Nocka 2002-06-11
6159461 Use of c-kit ligand with TNF-.alpha. and hematopoietic factors for the expansion or differentiation of hematopoietic cells Peter Besmer, Malcolm A. S. Moore, Karl Nocka 2000-12-12
6001803 Composition of c-kit ligand, GM-CSF, and TNF-.alpha. and method of use Peter Besmer, Malcolm A. S. Moore, Karl Nocka 1999-12-14
5962534 Regulating gene expression using retinoids with CH.sub.2 OH or related groups at the side chain terminal position Lorraine J Gudas, Charles Achkar, Alexander W. Langston, Fadila Derguini, Koji Nakanishi 1999-10-05
5935565 Method for increasing the level of stem cells in peripheral blood Peter Besmer, Malcolm A. S. Moore, Karl Nocka 1999-08-10
5928931 Isolation, purification and cloning of retinol dehydratase Felix Grun, Ulrich Hammerling 1999-07-27
5908868 Retinol derivatives useful for enhancing immune response Ulrich Hammerling, Fadila Derguini, Koji Nakanishi 1999-06-01
5883136 Anhydroretinol and derivatives thereof as antagonists of immune responses and inhibitors of cancer cell growth Ulrich Hammerling, Fadila Derguini, Koji Nakanishi 1999-03-16
5814612 Retinol derivatives and uses thereof Ulrich Hammerling, Fadila Derguini, Koji Nakanishi 1998-09-29
5786391 Regulating gene expression using retinoids with Ch.sub.2 OH or related groups at the side chain terminal position Lorraine J Gudas, Charles Achkar, Alexander W. Langston, Fadila Derguini, Koji Nakanishi 1998-07-28
5767074 Compositions of soluble C-kit ligand and hematopoietic factors Peter Besmer, Malcolm A. S. Moore, Karl Nocka 1998-06-16
5648563 Retro-alpha-retinol derivative and uses of retro-alpha-retinol Ulrich Hammerling, Fadila Derguini, Koji Nakanishi 1997-07-15
5610200 Anhydroretinol and derivatives thereof as antagonists of immune responses and inhibitors of cancer cell growth Ulrich Hammerling, Fadila Derguini, Koji Nakanishi 1997-03-11
5521221 Retro-.alpha.-retinol (4,14-retro-retinol) derivatives and uses of retro-.alpha.-retinol Ulrich Hammerling, Fadila Derguini, Koji Nakanishi 1996-05-28
5518914 Growth medium containing a complex of prealbumin, a retinoid and retinol-binding protein used to enhance B cell growth Urlich Hammerling 1996-05-21
5358972 Retro-alpha-retinol(4-14-retro-retinol) derivatives and uses of retro-.alpha.-retinol Ulrich Hammerling, Fadila Derguini, Koji Nakanishi 1994-10-25